These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30871874)

  • 1. Indomethacin plus minocycline coadministration relieves chemotherapy and antiretroviral drug-induced neuropathic pain in a cannabinoid receptors-dependent manner.
    Masocha W; Thomas A
    J Pharmacol Sci; 2019 Apr; 139(4):325-332. PubMed ID: 30871874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Caryophyllene, a CB2-Receptor-Selective Phytocannabinoid, Suppresses Mechanical Allodynia in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
    Aly E; Khajah MA; Masocha W
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31892132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors.
    Parvathy SS; Masocha W
    Sci Rep; 2015 Jun; 5():10541. PubMed ID: 26085115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.
    Deng L; Cornett BL; Mackie K; Hohmann AG
    Mol Pharmacol; 2015 Jul; 88(1):64-74. PubMed ID: 25904556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A; Okine BN; Finn DP; Masocha W
    Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
    Munawar N; Oriowo MA; Masocha W
    Front Pharmacol; 2017; 8():136. PubMed ID: 28373843
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
    Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
    Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery.
    Rahn EJ; Deng L; Thakur GA; Vemuri K; Zvonok AM; Lai YY; Makriyannis A; Hohmann AG
    Mol Pain; 2014 Apr; 10():27. PubMed ID: 24742127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB
    Li AL; Carey LM; Mackie K; Hohmann AG
    J Pharmacol Exp Ther; 2017 Aug; 362(2):296-305. PubMed ID: 28592614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal.
    Li AL; Lin X; Dhopeshwarkar AS; Thomaz AC; Carey LM; Liu Y; Nikas SP; Makriyannis A; Mackie K; Hohmann AG
    Mol Pharmacol; 2019 Feb; 95(2):155-168. PubMed ID: 30504240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
    Pascual D; Goicoechea C; Suardíaz M; Martín MI
    Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
    De Vry J; Denzer D; Reissmueller E; Eijckenboom M; Heil M; Meier H; Mauler F
    J Pharmacol Exp Ther; 2004 Aug; 310(2):620-32. PubMed ID: 15140913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.
    Curry ZA; Wilkerson JL; Bagdas D; Kyte SL; Patel N; Donvito G; Mustafa MA; Poklis JL; Niphakis MJ; Hsu KL; Cravatt BF; Gewirtz DA; Damaj MI; Lichtman AH
    J Pharmacol Exp Ther; 2018 Jul; 366(1):169-183. PubMed ID: 29540562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
    Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zerumbone Ameliorates Neuropathic Pain Symptoms via Cannabinoid and PPAR Receptors Using In Vivo and In Silico Models.
    Chia JSM; Farouk AAO; Mohamad TAST; Sulaiman MR; Zakaria H; Hassan NI; Perimal EK
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34202590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
    Jayamanne A; Greenwood R; Mitchell VA; Aslan S; Piomelli D; Vaughan CW
    Br J Pharmacol; 2006 Feb; 147(3):281-8. PubMed ID: 16331291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.
    Naguib M; Diaz P; Xu JJ; Astruc-Diaz F; Craig S; Vivas-Mejia P; Brown DL
    Br J Pharmacol; 2008 Dec; 155(7):1104-16. PubMed ID: 18846037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.